Covington and NautaDutilh advised NewAmsterdam Pharma on the deal, while Latham & Watkins advised Lincoln International. Houthoff assisted Frazier Lifesciences Acquisition Corp. NewAmsterdam Pharma Holding B.V.,...
NewAmsterdam Pharma’s DeSPAC Merger with Frazier Lifesciences
Sogelink’s Acquisition of Locatiqs
Loyens & Loeff advised Main Capital on the sale of Dutch developer of outdoor software Locatiqs to sogelink. Paul Hastings (Europe) LLP, NautaDutilh and Deloitte advised...
SendCloud’s $177 Million Series C Financing
NautaDutilh advised SoftBank Vision Fund 2 on the deal, while Latham & Watkins advised L Catterton and SoftBank Vision Fund 2. SendCloud, the leading e-commerce shipping...
bunq’s $228 Million Series A Round and Acquisition of Capitalflow Group
McCann FitzGerald advised Capitalflow and its owner Pollen Street Capital on the sale of Capitalflow to bunq and NautaDutilh advised Pollen Street Capital. Amsterdam-based challenger bank...
Mollie’s Series C Investment Round
NautaDutilh and Weil, Gotshal & Manges advised Blackstone Growth on the deal and De Brauw has advised Mollie. Freshfields Bruckhaus Deringer advised EQT Growth. Kennedy Van...
Keensight Capital’s Majority Investment in Symeres
NautaDutilh advised Keensight Capital on the deal. Loyens & Loeff advised Gilde Healthcare’s Private Equity. Keensight Capital completed its second direct investment in the Netherlands, being...
LAVA Therapeutics’ Nasdaq IPO
NautaDutilh assisted LAVA Therapeutics B.V. on the deal. LAVA Therapeutics B.V. (Nasdaq: LVTX) closed its IPO on the Nasdaq Global Market, raising approximately USD 100 million...